Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Generex receives FDA approval to begin human trials of oral insulin formulation

Nov. 26, 1998

New study will assess troglitazone in the prevention of IGT

Nov. 26, 1998

FDA and Pfizer revise labeling for Viagra, issue updated information

Nov. 25, 1998

Ergo Science receives unapprovable letter from FDA for Ergoset

Nov. 25, 1998

Heterocyclic hypoglycemic agents from SB for diabetes and related disorders

Nov. 24, 1998

Merck & Co. investigates sulfonamides as beta3-agonists with therapeutic potential in obesity

Nov. 23, 1998

Swedish launch announced for PDE5 inhibitor Viagra

Nov. 23, 1998

Merck & Co. presents potent and selective sst2 receptor agonists

Nov. 23, 1998

New raloxifene analogue is an even more potent and effective SERM than the parent compound

Nov. 23, 1998

New oral HRT option approved by FDA

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...